Venous thromboembolism and COVID-19.
作者信息
Bertoletti L, Couturaud F, Montani D, Parent F, Sanchez O
机构信息
Service de Médecine Vasculaire et Thérapeutique, Centre Hospitalo-Universitaire de Saint-Etienne, INSERM CIC 1408 and UMR 1059, FCRIN-INNOVTE, Université Jean Monnet, Saint-Étienne, France.
Département de Médecine Interne et Pneumologie, Centre Hospitalo-Universitaire de Brest, Université de Bretagne-Occidentale, EA 3878, CIC INSERM 1412, FCRIN-INNOVTE, Brest, France.
出版信息
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
Abstract
摘要
相似文献
1
Venous thromboembolism and COVID-19.静脉血栓栓塞与2019冠状病毒病
Respir Med Res. 2020 Nov;78:100759. doi: 10.1016/j.resmer.2020.100759. Epub 2020 Apr 28.
2
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.2019冠状病毒病、血栓形成前因素与静脉血栓栓塞症
Semin Thromb Hemost. 2020 Oct;46(7):772-776. doi: 10.1055/s-0040-1710337. Epub 2020 May 11.
3
Pulmonary Embolism in Patients With Covid-19 Pneumonia: The Utility of D-dimer.新冠肺炎患者的肺栓塞：D-二聚体的作用
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):758-759. doi: 10.1016/j.arbres.2020.06.013. Epub 2020 Jul 15.
4
Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection.简要研究：新型冠状病毒肺炎中的凝血功能障碍：确定和管理新型冠状病毒肺炎感染中的血栓形成风险
Clin Med (Lond). 2020 Jul;20(4):e59. doi: 10.7861/clinmed.rib.20.4.2.
5
Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19.科学与标准化委员会通讯：新型冠状病毒肺炎住院患者静脉血栓栓塞症诊断、预防及治疗的临床指南
J Thromb Haemost. 2020 Aug;18(8):1859-1865. doi: 10.1111/jth.14929.
6
COVID-19 and venous thromboembolism: current insights and prophylactic strategies.2019冠状病毒病与静脉血栓栓塞症：当前见解与预防策略
Ann Med. 2020 Sep;52(6):239-242. doi: 10.1080/07853890.2020.1791355. Epub 2020 Jul 13.
7
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
8
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
9
Focus on coronavirus disease 2019 associated coagulopathy.关注2019冠状病毒病相关凝血病。
Chin Med J (Engl). 2020 Sep 20;133(18):2239-2241. doi: 10.1097/CM9.0000000000001019.
10
Venous thromboembolism in non-critically ill patients with COVID-19 infection.COVID-19 感染非危重症患者的静脉血栓栓塞症。
Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17.
引用本文的文献
1
Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China.低分子量肝素在COVID-19住院患者中预防静脉血栓栓塞的真实世界实践：一项来自中国的多中心前瞻性研究。
Thromb J. 2025 Jun 20;23(1):69. doi: 10.1186/s12959-025-00741-9.
2
A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection.新型冠状病毒肺炎（COVID-19）感染相关血栓形成风险的病理生理机制、诊断及治疗综述
Int J Cardiol Heart Vasc. 2022 Aug;41:101068. doi: 10.1016/j.ijcha.2022.101068. Epub 2022 Jun 3.
3
COVID-19 and venous thromboembolism: A narrative review.新型冠状病毒肺炎与静脉血栓栓塞症：一篇叙述性综述。
Res Pract Thromb Haemost. 2022 Feb 15;6(2):e12666. doi: 10.1002/rth2.12666. eCollection 2022 Feb.
4
Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System.心血管系统中SARS-CoV-2感染的人类干细胞模型
Stem Cell Rev Rep. 2021 Dec;17(6):2107-2119. doi: 10.1007/s12015-021-10229-4. Epub 2021 Aug 8.
5
Systematic screening for a proximal DVT in COVID-19 hospitalized patients: Results of a comparative study.对 COVID-19 住院患者进行近端深静脉血栓形成的系统筛查：一项对比研究的结果。
J Med Vasc. 2021 Jul;46(4):163-170. doi: 10.1016/j.jdmv.2021.05.003. Epub 2021 May 14.
6
Thromboprophylaxis strategies to improve the prognosis of COVID-19.改善新型冠状病毒肺炎预后的血栓预防策略。
Vascul Pharmacol. 2021 Aug;139:106883. doi: 10.1016/j.vph.2021.106883. Epub 2021 Jun 4.
7
Statins and COVID-19: To Suspend or Not to Suspend? That is the Question!他汀类药物与新冠病毒病：停用还是不停用？这是个问题！
Arq Bras Cardiol. 2021 Jan;116(1):147-152. doi: 10.36660/abc.20200949.
8
Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection.新型冠状病毒肺炎与流感的免疫病理学相似性：探讨合并感染的后果。
Microb Pathog. 2021 Mar;152:104554. doi: 10.1016/j.micpath.2020.104554. Epub 2020 Nov 3.
9
A Severe COVID-19 Case Complicated by Right Atrium Thrombus.1例合并右心房血栓的重症新型冠状病毒肺炎病例
Am J Case Rep. 2020 Sep 23;21:e926915. doi: 10.12659/AJCR.926915.
10
How can we better predict pulmonary blood clots in patients hospitalised for COVID-19?我们如何才能更好地预测因 COVID-19 住院的患者的肺部血栓？
Eur Respir J. 2020 Oct 22;56(4). doi: 10.1183/13993003.03092-2020. Print 2020 Oct.
本文引用的文献
1
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞：一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
2
ISTH interim guidance on recognition and management of coagulopathy in COVID-19.国际血栓与止血学会（ISTH）关于新冠病毒病（COVID-19）凝血病识别与管理的临时指南。
J Thromb Haemost. 2020 May;18(5):1023-1026. doi: 10.1111/jth.14810. Epub 2020 Apr 27.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia.新型冠状病毒肺炎重型患者静脉血栓栓塞症发病情况。
J Thromb Haemost. 2020 Jun;18(6):1421-1424. doi: 10.1111/jth.14830. Epub 2020 May 6.
5
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2.严重新型冠状病毒肺炎与非新型冠状病毒肺炎患者凝血功能特征的差异。
J Thromb Thrombolysis. 2021 May;51(4):1107-1110. doi: 10.1007/s11239-020-02105-8.
6
The versatile heparin in COVID-19.新冠疫情中用途广泛的肝素。
J Thromb Haemost. 2020 May;18(5):1020-1022. doi: 10.1111/jth.14821. Epub 2020 Apr 27.
7
Acute pulmonary embolism and COVID-19 pneumonia: a random association?急性肺栓塞与新型冠状病毒肺炎：一种随机关联？
Eur Heart J. 2020 May 14;41(19):1858. doi: 10.1093/eurheartj/ehaa254.
8
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases.中国 2019 年冠状病毒病（COVID-19）的胸部 CT 与 RT-PCR 检测的相关性：1014 例报告。
Radiology. 2020 Aug;296(2):E32-E40. doi: 10.1148/radiol.2020200642. Epub 2020 Feb 26.
Zotero 插件